|
Gaydukova I.Z., Bashkinov A.R., Inamova O.V.
Topical non-steroidal antiinflammatory medicines in osteoarthritis treatment in patients with concomitant pathology
|
№10 / 2021
|
|
Shuginova T.N., Meldo A.A., Shaporova N.L., Moiseenko F.V., Klikunova K.A.
Pulmonary function test for chronic obstructive pulmonary disease patients with non-small cell lung cancer
|
№8 / 2021
|
|
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
|
№7 / 2021
|
|
Rukavishnikov G.V., Neznanov N.G., Martynov A.I., Mazo G.E.
Treatment of depression in patients with comorbid somatic diseases
|
№3 / 2020
|
|
Antropova O.N., Osipova I.V., Markina I.L., Vladimirova V.S., Rusakova A.A.
Clinical significance of non-cardial comboridity in patients with chronic heart failure
|
№3 / 2020
|
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Peculiarities of chronic heart failure in COPD patients
|
№5 / 2019
|
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|
|
Ju.V. Lukina
Atherosclerosis and comorbidity
|
№4 / 2018
|
|
E.V. Nadei, V.I. Sovalkin, G.I. Nechaeva, D.V. Turchaninov
Feasibility of achieving control of comorbid atopic bronchial asthma
|
№3 / 2018
|
|
Ye.I. Tarlovskaya
Problem of polymorbidity – challenge tо modern medicine
|
№2 / 2017
|
Русский
